Close

Alcobra Ltd. (ADHD) Reports on Productive FDA Meeting on ADAIR

February 6, 2017 4:02 PM EST Send to a Friend
Alcobra Ltd. (Nasdaq: ADHD) announced today that it has reached a regulatory milestone in the development of ADAIR (Abuse-Deterrent, Amphetamine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login